Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
This study has been completed.
Study NCT00253175 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: November 10, 2005 Last Updated: April 23, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vascular Headaches
Migraine
Additional conditions recognized in this trial
Headache
Migraine Disorders
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Headache Disorders
Headache Disorders, Primary
Headache Disorders, Secondary
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Ortho-McNeil Neurologics, Inc.
Back to top of Main Content
